Search

everythinglearnresearchcommunity

for

Search:↓

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

JAK inhibitors show promise in treating difficult skin diseases.

A CCS patient with severe complications was successfully treated using combined therapies.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Baricitinib works better than methotrexate for severe alopecia areata.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Baricitinib shows promise in treating severe hair loss.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib significantly improved skin and hair conditions without side effects.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

A patient with complete hair loss regrew all her hair using tofacitinib.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

The combination of encorafenib and binimetinib caused few skin issues.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

The FDA approved a new Pfizer drug for hair loss in teens.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.